Gottlieb Promotes 'Team' Work For Product Reviews

US FDA Commissioner intends to change agency's siloed structure and move reviewers into teams that will follow products pre- and post-market.

FDA commissioner Scott Gottlieb

US FDA Commissioner Scott Gottlieb intends to reorganize drug reviewers from multiple disciplines into teams that would handle a product's entire life-cycle, an attempt to break down the siloed nature of many areas within the agency.

More from Product Reviews

More from Pink Sheet